Literature DB >> 11229978

Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers.

N D Volkow1, L Chang, G J Wang, J S Fowler, D Franceschi, M J Sedler, S J Gatley, R Hitzemann, Y S Ding, C Wong, J Logan.   

Abstract

OBJECTIVE: Methamphetamine has raised concerns because it may be neurotoxic to the human brain. Although prior work has focused primarily on the effects of methamphetamine on dopamine cells, there is evidence that other neuronal types are affected. The authors measured regional brain glucose metabolism, which serves as a marker of brain function, to assess if there is evidence of functional changes in methamphetamine abusers in regions other than those innervated by dopamine cells.
METHOD: Fifteen detoxified methamphetamine abusers and 21 comparison subjects underwent positron emission tomography following administration of [(18)F]fluorodeoxyglucose.
RESULTS: Whole brain metabolism in the methamphetamine abusers was 14% higher than that of comparison subjects; the differences were most accentuated in the parietal cortex (20%). After normalization for whole brain metabolism, methamphetamine abusers exhibited significantly lower metabolism in the thalamus (17% difference) and striatum (where the differences were larger for the caudate [12%] than for the putamen [6%]). Statistical parametric mapping analyses corroborated these findings, revealing higher metabolism in the parietal cortex and lower metabolism in the thalamus and striatum of methamphetamine abusers.
CONCLUSIONS: The fact that the parietal cortex is a region devoid of any significant dopaminergic innervation suggests that the higher metabolism seen in this region in the methamphetamine abusers is the result of methamphetamine effects in circuits other than those modulated by dopamine. In addition, the lower metabolism in the striatum and thalamus (major outputs of dopamine signals into the cortex) is likely to reflect the functional consequence of methamphetamine in dopaminergic circuits. These results provide evidence that, in humans, methamphetamine abuse results in changes in function of dopamine- and nondopamine-innervated brain regions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11229978     DOI: 10.1176/appi.ajp.158.3.383

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  85 in total

Review 1.  [Neuroimaging in substance abuse disorders].

Authors:  A de Mendelssohn; S Kasper; J Tauscher
Journal:  Nervenarzt       Date:  2004-07       Impact factor: 1.214

Review 2.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

3.  Low frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex transiently increases cue-induced craving for methamphetamine: a preliminary study.

Authors:  Xingbao Li; Robert J Malcolm; Kristina Huebner; Colleen A Hanlon; Joseph J Taylor; Kathleen T Brady; Mark S George; Ronald E See
Journal:  Drug Alcohol Depend       Date:  2013-08-26       Impact factor: 4.492

4.  Bromocriptine increased operant responding for high fat food but decreased chow intake in both obesity-prone and resistant rats.

Authors:  Panayotis K Thanos; Jacob Cho; Ronald Kim; Michael Michaelides; Stefany Primeaux; George Bray; Gene-Jack Wang; Nora D Volkow
Journal:  Behav Brain Res       Date:  2010-10-27       Impact factor: 3.332

Review 5.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

Review 6.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

7.  Emotion, decision-making and substance dependence: a somatic-marker model of addiction.

Authors:  A Verdejo-García; M Pérez-García; A Bechara
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

8.  Connection between the striatal neurokinin-1 receptor and nitric oxide formation during methamphetamine exposure.

Authors:  Jing Wang; Wenjing Xu; Syed F Ali; Jesus A Angulo
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

9.  Visual information processing in recently abstaining methamphetamine-dependent individuals: evoked potentials study.

Authors:  Jan Kremlácek; Ladislav Hosák; Miroslav Kuba; Jan Libiger; Jirí Cízek
Journal:  Doc Ophthalmol       Date:  2008-06-19       Impact factor: 2.379

Review 10.  Abuse of amphetamines and structural abnormalities in the brain.

Authors:  Steven Berman; Joseph O'Neill; Scott Fears; George Bartzokis; Edythe D London
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.